Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China
Open Access
- 9 March 2011
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 63 (5), 1182-1189
- https://doi.org/10.1002/art.30277
Abstract
Objective To examine the life expectancy, standardized mortality ratios (SMRs), and causes of death in 6 groups of patients from Hong Kong with different rheumatic diseases. Methods Patients with a diagnosis of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), systemic vasculitis (SV), or systemic sclerosis (SSc) registered in 37 public hospitals between 1999 and 2008 were identified in the hospital registry. SMRs were calculated by comparing the mortality rate in patients with each disease with that in the general population. Life expectancy was calculated by abridged life-table analysis, and the causes of death were compared. Results In 2008, data on 8,367 RA, 5,243 SLE, 2,154 AS, 1,636 SV, 778 PsA, and 449 SSc patients were available in our registry. The age- and sex-adjusted SMRs were highest for SLE (5.25 [95% confidence interval 4.79–5.70]), SSc (3.94 [95% confidence interval 3.20–4.68]), and SV (2.64 [95% confidence interval 2.36–2.93]). In female patients, the loss in life expectancy was greatest for SSc (34.1 years), SV (19.3 years), and SLE (19.7 years). In male patients, the loss in life expectancy was highest for SV (28.3 years), SLE (27 years), and SSc (16 years). There were 2,486 deaths during the study period (1999–2008), and the principal causes were infections (28%), cardiovascular complications (18%), cancer (16%), and disease activity (7%). Infection was the leading cause of death in SLE, RA, AS, and PsA, whereas deaths from disease-related activity and cardiovascular complications were most frequent in SSc. Cancer was the most common cause of death in SV. Conclusion Our findings indicate that patients with SLE, RA, AS, PsA, SV, and SSc have increased mortality rates and reduced life expectancy. SLE has the highest adjusted SMR, and female SSc patients have the greatest loss in life expectancy. Infection is the leading cause of death, followed by cardiovascular complications and malignancies.Keywords
This publication has 30 references indexed in Scilit:
- Childhood‐onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosusArthritis Care & Research, 2010
- High risk of clinical cardiovascular events in rheumatoid arthritis: Levels of associations of myocardial infarction and stroke through a systematic review and meta-analysisArchives of Cardiovascular Diseases, 2010
- Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritisArthritis Care & Research, 2009
- Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosusScandinavian Journal of Rheumatology, 2009
- Changing Patterns in Mortality and Disease Outcomes for Patients with Systemic Lupus ErythematosusThe Journal of Rheumatology, 2008
- Cardiovascular morbidity in psoriatic arthritisAnnals Of The Rheumatic Diseases, 2008
- HLA–DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritisArthritis Care & Research, 2007
- Long-term Survival of Southern Chinese Patients With Systemic Lupus ErythematosusMedicine, 2005
- Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritisArthritis Research & Therapy, 2005
- Statistical Models Based on Counting ProcessesSpringer Series in Statistics, 1993